Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exacerbation Profile in Patients on Mepolizumab for Severe Refractory Eosinophilic Asthma- an Exploratory Study.

NCT03324230 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.

NCT NCT03324230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03324230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exacerbation Profile in Patients on Mepolizumab for Severe Refractory Eosinophilic Asthma- an Exploratory Study.
Lead sponsor
Queen's University, Belfast
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
June 29, 2019
Enrollment
146 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

asthma brittle